Live Breaking News & Updates on Lapam Capital

Stay updated with breaking news from Lapam capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BridGene raises $38.5m to develop IMTAC platform and cancer drugs

BridGene has raised $38.5m in Series B financing round to develop its chemoproteomic platform, IMTAC, as well as oncology drugs. ....

Lapam Capital , Junson Capital , Dyee Capital , Ping Cao ,

BridGene Biosciences Raises $38.5M in Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

Bridgene Biosciences Inc , Bridgene Biosciences , San Jose , Lapam Capital , Junson Capital , Ping Cao ,